| Typicality: | 0.381 |
| Saliency: | 0.308 |
| for alfataliglicerase in brazil | 8 | transitive-object |
| risk → be associated with → product commercialization | 10 |
| risk → be related to → our commercialization efforts | 8 |
| risk → be associated with → commercialization | 3 |
| negative | neutral | positive |
| 0.483 | 0.492 | 0.025 |
| Raw frequency | 21 |
| Normalized frequency | 0.308 |
| Modifier score | 0.500 |
| Perplexity | 106.600 |